List of works - João M Frazão

A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism

scientific article published on 01 July 2000

Adynamic bone disease: clinical and therapeutic implications.

scientific article published on July 2009

Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council

article

Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet)

scientific article

Calciphylaxis: from the disease to the diseased.

scientific article published on 03 April 2015

Cardiovascular risk in dialysis patients: an X-ray vision on vascular calcifications

scientific article published on 01 December 2008

Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity

scientific article published on September 1, 2011

Cortical bone analysis in a predialysis population: a comparison with a dialysis population.

scientific article published on 9 November 2016

Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats.

scientific article

Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients

scientific article published on 16 January 2008

Epstein-Barr-virus-induced interstitial nephritis in an HIV-positive patient with progressive renal failure.

scientific article published in July 1998

Evaluation of parathyroid gland angiogenesis in chronic kidney disease associated with secondary hyperparathyroidism.

scientific article published on 08 April 2008

Evolution of bone disease after kidney transplantation: A prospective histomorphometric analysis of trabecular and cortical bone.

scientific article published in January 2016

Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients

scientific article

Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet

scientific article published on 10 April 2009

Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism

scientific article published on 01 September 2000

Intermittent oral 1&agr;-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients ⬇️

scientific article published on January 1, 1998

Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism? ⬇️

scientific article published on August 3, 2012

Low bone volume--a risk factor for coronary calcifications in hemodialysis patients

scientific article published on 21 January 2009

Non-calcium-containing phosphate binders: comparing efficacy, safety, and other clinical effects

scientific article published on 28 April 2012

Nutrition and dietary intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD, a prospective multinational cohort study

scientific article

Parathyroidectomy in Persistent Post-transplantation Hyperparathyroidism - Single-center Experience

scientific article published in May 2017

Secondary hyperparathyroidism disease stabilization following calcimimetic therapy

scientific article published on January 2008

The calcimimetic agents: perspectives for treatment.

scientific article

The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives.

scientific article published on 29 July 2016

The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder.

scientific article published on 25 October 2013

Therapeutic implications of heparin-induced thrombocytopenia complicating acute hemodialysis.

scientific article

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data.

scientific article

[Primary amyloidosis associated with kappa light chain myeloma]

scientific article published on 01 March 2010

[Significance of digestive hemorrhage in patients with chronic renal insufficiency in hemodialysis]

scientific article published on 01 February 1992

List of works by João M Frazão

A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism

Adynamic bone disease: clinical and therapeutic implications.

Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council

Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet)

Calciphylaxis: from the disease to the diseased.

Cardiovascular risk in dialysis patients: an X-ray vision on vascular calcifications

Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity

Cortical bone analysis in a predialysis population: a comparison with a dialysis population.

Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats.

Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients

Epstein-Barr-virus-induced interstitial nephritis in an HIV-positive patient with progressive renal failure.

Evaluation of parathyroid gland angiogenesis in chronic kidney disease associated with secondary hyperparathyroidism.

Evolution of bone disease after kidney transplantation: A prospective histomorphometric analysis of trabecular and cortical bone.

Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients

Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet

Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism

Intermittent oral 1&amp;agr;-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients ⬇️

Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism? ⬇️

Low bone volume--a risk factor for coronary calcifications in hemodialysis patients

Non-calcium-containing phosphate binders: comparing efficacy, safety, and other clinical effects

Nutrition and dietary intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD, a prospective multinational cohort study

Parathyroidectomy in Persistent Post-transplantation Hyperparathyroidism - Single-center Experience

Secondary hyperparathyroidism disease stabilization following calcimimetic therapy

The calcimimetic agents: perspectives for treatment.

The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives.

The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder.

Therapeutic implications of heparin-induced thrombocytopenia complicating acute hemodialysis.

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data.

[Primary amyloidosis associated with kappa light chain myeloma]

[Significance of digestive hemorrhage in patients with chronic renal insufficiency in hemodialysis]

Intermittent oral 1&agr;-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients ⬇️